Document Type : Letter to Editor
Authors
- Amir Sasan Mozaffari Nejad 1, 2, 3
- Ariyo Shahin Jafari 4
- Ahmed S Abdel-Moneim 5
- Hakime Karami 6
- Behrooz Ataei 2
- Sara Mohammed Ali 7
1 Bio Environmental Health Hazards Research Center, Jiroft University of Medical Sciences, Jiroft, Iran
2 Infectious Disease and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
3 Universal Scientific Education and Research Network (USERN) JMU Office, Jiroft University of Medical Sciences, Jiroft, Iran
4 Department of Medical Parasitology and Virology, Sechenov University, Moscow, Russia
5 Department of Microbiology and Immunology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Sultanate of Oman
6 Information System and Technology Management, College of Technological Innovation, Zayed University, Dubai, UAE
7 Department of Medical Laboratory Science, College of Health Science, Gulf Medical University, Ajman, UAE
Abstract
Despite widespread vaccination, SARS-CoV-2 continues to circulate in waves, highlighting the need to better understand the multifactorial determinants of vaccine efficacy. Beyond its immediate health impact, the pandemic has intensified skepticism toward vaccines – a phenomenon with historical precedent dating back to Edward Jenner (1). Current hesitancy often arises from adverse effects, the accelerated pace of vaccine development, competition among pharmaceutical companies, and the proliferation of misinformation. While some concerns are evidence-based, many reflect perceived opacity from developers and political influence, as well as rumors.
We hypothesize that negative attitudes toward vaccination may directly compromise immune responses. Psychological stress, anxiety, and depression can alter the neuroimmune axis, reducing both cellular and humoral immunity. This may partly explain suboptimal vaccine responses during COVID-19 and could influence outcomes in future pandemics.
Keywords
Main Subjects
- Facciolà A, Visalli G. Past and future of vaccinations: from jenner to nanovaccinology. Vaccines (Basel) 2023;11(2):384. doi:10.3390/vaccines11020384
- Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med 2020;383(27):2603-15. doi:10.1056/NEJMoa2034577
- Zimmermann P, Curtis N. Factors that influence the immune response to vaccination. Clin Microbiol Rev 2019;32(2):e00084-18. doi:10.1128/cmr.00084-18
- Solomon GF. Psychoneuroimmunology: interactions between central nervous system and immune system. J Neurosci Res 1987;18(1):1-9. doi:10.1002/jnr.490180103
- Aghayan SK, Shabani AH, Badri T, Hosseni Nejad J, Esmaeili Gouvrchin Ghaleh H. Relationship between stress and the immune system-related disorders. Int J Med Rev 2024;11(3):775-85. doi:10.30491/IJMR.2024.468527.1288
- Shahin-Jafari A, Agah S, Massadeh MI, Valizadeh M, Karami H, Mozaffari Nejad AS. Unraveling the intricacies of gut microbiome, psychology, and viral pandemics: a holistic perspective. Jordan J Biol Sci 2025;18(1):1-2.
- Cohen S, Janicki-Deverts D, Miller GE. Psychological stress and disease. JAMA 2007;298(14):1685-7. doi:10.1001/ jama.298.14.1685
- Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: implications for health. Nat Rev Immunol 2005;5(3):243-51. doi:10.1038/nri1571
- Dhabhar FS. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. Neuroimmunomodulation 2009;16(5):300-17. doi:10.1159/000216188
- Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 2004;130(4):601-30. doi:10.1037/0033- 2909.130.4.601
- Kemeny ME. The psychobiology of stress. Curr Dir Psychol Sci 2003;12(4):124-9. doi:10.1111/1467-8721.01246
- Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, et al. An mRNA vaccine against SARS-CoV-2 - preliminary report. N Engl J Med 2020;383(20):1920-31. doi:10.1056/NEJMoa2022483
- Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, et al. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N Engl J Med 2020;383(25):2427-38. doi:10.1056/NEJMoa2028436
- Shahgolzari M, Yavari A, Arjeini Y, Miri SM, Darabi A, Mozaffari Nejad AS, et al. Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn. Gene Rep 2021;25:101417. doi:10.1016/j. genrep.2021.101417
- Faustman D, Davis M. TNF receptor 2 pathway: drug target for autoimmune diseases. Nat Rev Drug Discov 2010;9(6):482- 93. doi:10.1038/nrd3030
- Calcagni E, Elenkov I. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann N Y Acad Sci 2006;1069:62-76. doi:10.1196/ annals.1351.006
- Padgett DA, Glaser R. How stress influences the immune response. Trends Immunol 2003;24(8):444-8. doi:10.1016/ s1471-4906(03)00173-x
- Alotiby A. Immunology of stress: a review article. J Clin Med 2024;13(21):6394. doi:10.3390/jcm13216394
- Pigott DM, Golding N, Mylne A, Huang Z, Weiss DJ, Brady OJ, et al. Mapping the zoonotic niche of Marburg virus disease in Africa. Trans R Soc Trop Med Hyg 2015;109(6):366-78. doi:10.1093/trstmh/trv024
- Ukoaka BM, Okesanya OJ, Daniel FM, Ahmed MM, Udam NG, Wagwula PM, et al. Updated WHO list of emerging pathogens for a potential future pandemic: Implications for public health and global preparedness. Infez Med 2024; 32(4):463-477. doi:10.53854/liim-3204-5
- Jafari AS, Mozaffari Nejad AS, Faraji H, Abdel-Moneim AS, Asgari S, Karami H, et al. Diagnostic challenges in fungal coinfections associated with global COVID-19. Scientifica 2025;2025(1):6840605. doi:10.1155/sci5/6840605
)